Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$465M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$445M |
| 4 |
Kenvue
KVUE
|
+$434M |
| 5 |
Micron Technology
MU
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.24B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Microsoft
MSFT
|
+$1.56B |
| 4 |
PepsiCo
PEP
|
+$1.34B |
| 5 |
JPMorgan Chase
JPM
|
+$1.34B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.7% |
| 2 | Financials | 7.47% |
| 3 | Consumer Discretionary | 6.7% |
| 4 | Communication Services | 6.02% |
| 5 | Healthcare | 4.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3501
Oak Valley Bancorp
OVLY
$285M
| $860K | ﹤0.01% |
28,594
+931
| +3% | +$26.3K |
|
3502
CALL
Eos Energy Enterprises
EOSE
$1.53B
| $860K | ﹤0.01% |
75,000
-300,000
| -80% | -$4.31M |
|
|
PENG
3503
CALL
Penguin Solutions Inc
PENG
$3.2B
| $857K | ﹤0.01% |
+43,800
| New | +$938K |
|
3504
HealthStream
HSTM
$835M
| $857K | ﹤0.01% |
37,132
+2,381
| +7% | +$59.9K |
|
3505
Playtika
PLTK
$950M
| $853K | ﹤0.01% |
216,016
-89,417
| -29% | -$350K |
|
|
ILPT
3506
Industrial Logistics Properties Trust
ILPT
$605M
| $853K | ﹤0.01% |
153,953
+7,990
| +5% | +$44.2K |
|
3507
N-able
NABL
$654M
| $852K | ﹤0.01% |
113,909
+5,977
| +6% | +$45.6K |
|
3508
Stagwell
STGW
$2.26B
| $852K | ﹤0.01% |
174,181
+8,944
| +5% | +$46.5K |
|
3509
Madison Square Garden
MSGS
$10.1B
| $852K | ﹤0.01% |
3,293
+648
| +24% | +$148K |
|
|
YB
3510
Yuanbao Inc
YB
$633M
| $851K | ﹤0.01% |
41,988
+17,105
| +69% | +$362K |
|
|
UROY
3511
CALL
Uranium Royalty Corp
UROY
$1.57B
| $850K | ﹤0.01% |
+240,000
| New | +$939K |
|
|
DOO
3512
Bombardier Recreational Products
DOO
$4.75B
| $847K | ﹤0.01% |
11,971
+9,100
| +317% | +$620K |
|
3513
GoodRx Holdings
GDRX
$1.24B
| $847K | ﹤0.01% |
312,465
-5
| -0% | -$16 |
|
3514
Xerox
XRX
$411M
| $844K | ﹤0.01% |
356,101
-1,251,277
| -78% | -$3.7M |
|
3515
Alpha and Omega Semiconductor
AOSL
$901M
| $843K | ﹤0.01% |
42,576
-40,021
| -48% | -$945K |
|
3516
Assembly Biosciences
ASMB
$590M
| $841K | ﹤0.01% |
24,741
+20,780
| +525% | +$669K |
|
3517
Greene County Bancorp
GCBC
$600M
| $841K | ﹤0.01% |
37,842
-4,026
| -10% | -$91.4K |
|
3518
Hippo Holdings
HIPO
$868M
| $839K | ﹤0.01% |
27,906
+2,707
| +11% | +$90.5K |
|
3519
Opko Health
OPK
$1.04B
| $836K | ﹤0.01% |
663,236
+75,483
| +13% | +$105K |
|
3520
Consolidated Water Co
CWCO
$506M
| $830K | ﹤0.01% |
23,531
+2,269
| +11% | +$79.2K |
|
3521
El Pollo Loco
LOCO
$464M
| $828K | ﹤0.01% |
79,170
+6,486
| +9% | +$67K |
|
3522
Domo
DOMO
$183M
| $824K | ﹤0.01% |
97,715
+6,406
| +7% | +$75.3K |
|
3523
CALL
Amer Sports
AS
$19.1B
| $822K | ﹤0.01% |
22,000
-109,500
| -83% | -$3.76M |
|
3524
iShares Core S&P Mid-Cap ETF
IJH
$128B
| $821K | ﹤0.01% |
12,435
-99,497
| -89% | -$6.52M |
|
3525
PUT
Honeywell
HON
$74.2B
| $819K | ﹤0.01% |
4,200
-47,789
| -92% | -$9.35M |
|
Similar funds
Barclays's Q4 2025 Portfolio in Review
As of Q4 2025, Barclays held 5,847 positions worth $417B, down 9.7% from $461B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Barclays withdrew a net $49.1B in Q4 2025, closing 641 positions and reducing 1,715 holdings. Its most notable exit was Verona Pharma, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in The Magnum Ice Cream Company N.V. worth $156M.
- Barclays's largest Q4 2025 buy was The Magnum Ice Cream Company N.V.: 9,862,859 shares worth $156M.
- Barclays added most to Gilead Sciences in Q4 2025, an estimated $479M increase.
- Barclays's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $3.24B.
- Barclays fully exited Verona Pharma in Q4 2025, selling an estimated $149M.
- Barclays's ten largest holdings make up 35% of its $417B portfolio in Q4 2025.
- Barclays opened 403 new positions and closed 641 in Q4 2025.
- Barclays's portfolio value fell 9.7% quarter-over-quarter to $417B.
Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.